Vanderbilt-Ingram Cancer Center
MD Anderson Cancer Center
Nashville, United States
Cathy Eng, MD, FACP, FASCO, Professor of Medicine, Hematology and Oncology, is the David H. Johnson Endowed Chair of Surgical and Medical Oncology, Co-Director of GI Oncology and the Co-Leader of the Gastrointestinal Cancer Research Program, Director of the new Young Adults Cancers Program, and the Chair, Developmental Research Program for the GI SPORE, at the Vanderbilt-Ingram Cancer Center. She has served on the Scientific Review Committee and remains on the Clinical Trials Shared Resource Oversite Committee. She has focused on the development of phase I-III clinical trials using novel therapeutics for biomarker discovery and enhanced drug utilization in colorectal, appendiceal and anal cancer patients.
Nationally, Dr. Eng serves on ASCO, ECOG, SWOG and the NCI. She served on multiple committees for ASCO; ASCO Scientific Program Committee Track Leader for the Gastrointestinal Cancer-Colorectal/Liver Track and served on the Steering Committee 2012-2015. She is the former Chairman of the Scientific Program Committee of the ASCO Gastrointestinal Cancer Symposium from 2012-2013 and Chairman, Steering Committee, GI Cancers Symposium 2016. She was chosen for the ASCO Leadership Development Program and served on the ASCO Government Relations Committee; ASCO Cancer Prevention Committee on the consensus statement regarding HPV vaccination; served on the ASCO Nausea and Vomiting Guidelines Committee, ASCO Taxonomy Task Force, ASCO Social Media Committee, and is currently on the ASCO Colorectal Guidelines Committee, ASCO Scientific Program Committee and the ASCO Communications Committee. She serves on the NCI GI Steering Committee, and is now the co-Chair of the NCI GI Steering Committee.
Friday, July 1, 2022
08:00 – 09:25
Friday, July 1, 2022
12:20 – 12:40
Saturday, July 2, 2022
16:03 – 16:25